Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 2, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Kena Zhou1,2, Leheng Liu1,2, Jingpiao Bao1,2
1Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, People's Republic of China.
Interleukin-18 (IL-18) is a key biomarker for acute pancreatitis (AP). Elevated IL-18 predicts prognosis and immune responses, while increased IL-18 suggests a lower risk of developing AP.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: